Fulgent Genetics (NASDAQ:FLGT – Get Rating) issued an update on its FY23 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of ($1.25) for the period, compared to the consensus estimate of ($1.65). Fulgent Genetics Trading Up 19.0 % FLGT stock opened at $33.93 on Monday. The firm has a 50-day […]
Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Rating)’s stock price was down 4.6% during trading on Monday . The company traded as low as $32.11 and last traded at $32.36. Approximately 95,985 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 216,610 shares. The stock had previously closed at […]
Fulgent Genetics (NASDAQ:FLGT – Get Rating) updated its FY23 earnings guidance on Friday. The company provided EPS guidance of ($1.25) for the period, compared to the consensus EPS estimate of ($1.65). Analyst Upgrades and Downgrades A number of equities analysts recently issued reports on the company. Piper Sandler dropped their price objective on Fulgent Genetics […]
Fulgent Genetics (NASDAQ:FLGT – Get Rating) updated its FY 2023 earnings guidance on Sunday. The company provided earnings per share (EPS) guidance of -$1.25–$1.25 for the period, compared to the consensus estimate of -$1.26. The company issued revenue guidance of $250.00 million-$250.00 million, compared to the consensus revenue estimate of $250.17 million. Fulgent Genetics also […]
Total Revenue of $66.2 million
Record Core Revenue of $62.7 million, growth of 150% year-over-year
Raises Full Year 2023 Core Revenue Guidance to $250 million
. | May 5, 2023